HYDROXYZINE

Post-LOE

hydroxyzine hydrochloride

Baxter

ANDAINJECTIONINJECTABLE

Approved

Aug 1979

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

HYDROXYZINE (hydroxyzine hydrochloride) by Baxter is clinical pharmacology hydroxyzine hydrochloride is unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines. Approved for anxiety. First approved in 1979.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Hydroxyzine hydrochloride is unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines. Hydroxyzine is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the…

Indications (1)

anxiety

Clinical Trials (1)

NCT01250652Phase 4Completed

Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses

Started Mar 2011

24 enrolled

Chronic Urticaria

Worked on HYDROXYZINE at Baxter? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.